RARE — Ultragenyx Pharmaceutical Inc. stock price, charts and financials

QT50Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
26.80
+0.89+3.44%
OverviewShort InterestFilings
RAREQT50Ultragenyx Pharmaceutical Inc.·NASDAQ
26.80+3.44%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 202610-QQuarterly report
Aug 04, 20264Statement of changes in beneficial ownership
Aug 04, 20268-KCurrent report
Aug 04, 20264Statement of changes in beneficial ownership
Jul 31, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 30, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 06, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 12, 2026S-8Registration of employee benefit securities
Jun 01, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20268-KCurrent report
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 06, 20264Statement of changes in beneficial ownership
May 06, 202610-QQuarterly report
May 05, 20268-KCurrent report
#1 / 25 of 346
Page
▼
/ 14